The store will not work correctly when cookies are disabled.
3-[(2,3,5,6-Tetramethyl-4-oxocyclohexa-2,5-dien-1-ylidene)amino]benzoicacid
ID: ALA2283228
PubChem CID: 76330906
Max Phase: Preclinical
Molecular Formula: C17H17NO3
Molecular Weight: 283.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC1=C(C)C(=Nc2cccc(C(=O)O)c2)C(C)=C(C)C1=O
Standard InChI: InChI=1S/C17H17NO3/c1-9-11(3)16(19)12(4)10(2)15(9)18-14-7-5-6-13(8-14)17(20)21/h5-8H,1-4H3,(H,20,21)
Standard InChI Key: ISFKGBVARWDHQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
24.0832 -7.4606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0820 -8.2914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8004 -8.7081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5163 -8.2909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5134 -7.4570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7986 -7.0481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2298 -7.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2268 -6.2136 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3692 -7.0485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9448 -7.4524 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6554 -7.4609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9434 -7.0441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2318 -7.4529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2277 -8.2776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9416 -8.6918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6594 -8.2813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3735 -8.6932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9390 -9.5161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5194 -7.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9469 -6.2198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5124 -8.6872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
1 9 1 0
7 10 1 0
9 11 2 0
11 12 1 0
11 16 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
15 18 1 0
13 19 1 0
12 20 1 0
14 21 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 283.33 | Molecular Weight (Monoisotopic): 283.1208 | AlogP: 3.71 | #Rotatable Bonds: 2 |
Polar Surface Area: 66.73 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.70 | CX Basic pKa: 3.75 | CX LogP: 4.08 | CX LogD: 1.70 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: -0.26 |
References
1. Bansal SK, Sinha BN, Khosa RL. (2013) -Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation, 22 (1): [10.1007/s00044-012-0023-0] |